Haemonetics director Charles Dockendorff to step down after 12-year tenure

Filed May 1, 2026 · Period ending April 27, 2026 · ~1 min read

Key Changes

• low

  Board member Charles J. Dockendorff will not seek re-election at the 2026 Annual Meeting, ending a 12-year tenure that began in 2014. He currently serves on both the Audit and Governance committees.

  Item 5.02 verify on EDGAR →
• low

  Dockendorff will continue serving as director and in his committee roles until the Annual Meeting. The company explicitly stated his departure is not due to any disagreement with management or the board.

  8-K: Director Departure verify on EDGAR →